Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD Meeting Abstract


Authors: Gupta, D. M.; Devlin, D. S.; Tallman, D. M.; Stein, D. E.
Abstract Title: Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD
Meeting Title: 22nd Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 102
Issue: Suppl. 2
Meeting Dates: 2017 Jun 22-25
Meeting Location: Madrid, Spain
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2017-06-26
Start Page: 212
End Page: 213
Language: English
ACCESSION: WOS:000404127002046
PROVIDER: wos
PMCID: PMC5492673
Notes: Meeting Abstract: P553 -- Source: Wos